Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

New sublingual beta-blocker enters phase IIb trial in angina pectoris

July 1, 1999

Novel tyrphostins with antiproliferative activity via inhibition of PDGF receptor tyrosine kinase

July 1, 1999

Nitroderivative of aspirin endowed with significant myocardial protective effects

June 30, 1999

Piperidines synthesized at Toa Eiyo act as 5-HT2 antagonists and antiplatelet agents

June 30, 1999

New benzothiophene ET antagonists from Pfizer

June 30, 1999

Bradykinin mimic reduces myocardial infarct size in rat model

June 29, 1999

Antiischemic and cytoprotective agents from Taisho act via inhibition of Na+/Ca2+ exchange

June 29, 1999

Adenosine binding and uptake inhibitors in the Kyowa Hakko pipeline

June 29, 1999

Antiarrhythmic drug to move into phase II trials at CV Therapeutics

June 29, 1999

AC-6 gene shows positive preclinical results in cardiomyopathy

June 25, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...